(Q38390096)

2 September 2017

Toward the harmonization of result presentation for the eosin-5'-maleimide binding test in the diagnosis of hereditary spherocytosis (English)

1 reference

2 September 2017

Linda Hunt

1

1 reference

2 September 2017

David Greenwood

2

1 reference

2 September 2017

Hermann Heimpel

3

1 reference

2 September 2017

Nigel Noel

4

1 reference

2 September 2017

Alastair Whiteway

5

1 reference

2 September 2017

May-Jean King

6

1 reference

2 September 2017

16 September 2014

1 reference

Cytometry Part B: Clinical Cytometry

2 September 2017

1 reference

2 September 2017

88

1 reference

2 September 2017

1

1 reference

2 September 2017

50-57

1 reference

Hereditary red cell membrane disorders and laboratory diagnostic testing

2 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

Eosin-5-maleimide binding to band 3 and Rh-related proteins forms the basis of a screening test for hereditary spherocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

The mutant erythrocyte band 3 protein in Southeast Asian ovalocytosis does not bind eosin-5-maleimide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

Diagnostic power of laboratory tests for hereditary spherocytosis: a comparison study in 150 patients grouped according to molecular and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

Flow cytometric detection of erythrocyte osmotic fragility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

Flow cytometric osmotic fragility--an effective screening approach for red cell membranopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

Flow cytometric osmotic fragility testing does reflect the clinical severity of hereditary spherocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

Roadmap for harmonization of clinical laboratory measurement procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

Usefulness of the eosin-5'-maleimide cytometric method as a first-line screening test for the diagnosis of hereditary spherocytosis: comparison with ektacytometry and protein electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

Testing for hereditary spherocytosis: a French experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

Flow cytometry test for hereditary spherocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

Guidelines for the diagnosis and management of hereditary spherocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part I - rationale and aims.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part II - preanalytical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part III - analytical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part IV - postanalytic considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part V - assay performance criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

Detection of hereditary pyropoikilocytosis by the eosin-5-maleimide (EMA)-binding test is attributable to a marked reduction in EMA-reactive transmembrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

Evaluation of eosin-5-maleimide flow cytometric test in diagnosis of hereditary spherocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

Evaluation of red cell membrane cytoskeletal disorders using a flow cytometric method in South iran.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21187

21 January 2018

Identifiers

DOI

10.1002/CYTO.B.21187

1 reference

2 September 2017

1 reference